ToxStrategies is excited to be returning to present and exhibit at The Society of Toxicology’s Annual Meeting, March 19th through March 23rd. The meeting is in Nashville, TN, at the Music City Center
Come by and see us at Booth #628!
- A Tiered Approach for Assessing the Safety of Polymeric Ingredients in Cosmetics and Personal Care Products; L. Brown, D.A. McMillan, J.D. Urban, and A.L. Mihalchik
- Reliability Assessment of Guideline-Based Studies Using Systematic Review Critical Appraisal Tools; N.Y. Choksi, S. Fitch, M.A. Harris, C.M. Thompson, and D.S. Wikoff
- Using NHANES Data to Characterize the Magnitude of Allostatic Load in Vulnerable Communities: Impact to Existing Risk Assessment Uncertainty/Variability Factors; A. East, W. Rish, and W.D. Klaren
- Development of a Study Quality Tool for Use in a Systematic Review of Literature Reporting Microplastic Exposure and Reproductive and Developmental Toxicity; S. Fitch, J. Rogers, S. Marty1, R. Ellis-Hutchings1, R. Becker2, and D. Wikoff; 1 Dow Chemical Company, Midland, MI; 2 American Chemistry Council, Washington, DC
- Risk Assessment of Three Smoke Flavoring Primary Products Currently Under Re-Evaluation by EFSA; A.C. Franzen, C.M. Thompson, G.P. Brorby, D.S. Wikoff, Z. Ilkbahar1, C. Doepker; 1 Kerry Inc., Naas, Ireland
- Updated Mode of Action Information Informing the Risk Assessment of HFPO-DA (GenX); L.C. Haws, M.M. Heintz, and C.M. Thompson
- Assessment of the Mode of Action Underlying Development of Liver Lesions in Mice Following Oral Exposure to HFPO-DA (GenX) and Relevance to Humans; M.M. Heintz, L.C. Haws, and C.M. Thompson
- In Vitro Transcriptomic Analyses Informing the Mode of Action of HFPO-DA (GenX) in the Liver; W.D. Klaren, M.M. Heintz, A.W. East, C.M. Thompson, and L.C. Haws
- Weight-of-Evidence Evaluation of Endocrine Activity for Di-Isodecyl Phthalate (DIDP) and Di-Isononyl Phthalate (DINP); I.A. Lea, M.M. Heintz, D. Feifarek, L.C. Haws, and S.J. Borghoff
- Toward Best Practices for Read-Across in Evaluation of Drug Impurities, Extractable, and Leachable Compounds; A.L. Mihalchik, N.Y. Choksi, and M.L. Wood
- Relative Oral Bioavailability of Manganese in Electric Arc Furnace Steel Slag is Influenced by High Iron Content and Low Bioaccessibility; D.M. Proctor, S. Vivanco, and A. Blanchette
- The Influences of Household Behavior, Environmental, and Demographic Factors on Indoor and Outdoor Air Quality; B.N. Rivera, L. Bramer1, C.C. Ghetu2, D. Rohlman3, K. Adams2, K. Waters1, and K.A. Anderson2; 1 – Pacific Northwest National Laboratory, Biological Sciences Division, Richland, WA; 2 – Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR; 3 – College of Public Health and Human Sciences, Oregon State University, Corvallis OR
- Scoping Review of the Immunomodulatory Effects of Cannabidiol: Effects within T cells; B.N. Rivera, A. Svetlik1, W.D. Klaren, D.S. Wikoff, and R.G. Henderson; 1 – Texas A&M University, College Station, TX
- An Evaluation of Risk Assessments on Hexavalent Chromium [Cr(VI)]: The Past, Present, and Future of Mode of Action Research; C.M. Thompson, D.S. Wikoff, D.M. Proctor, and M.A. Harris
- Tailoring Off-the-Shelf Systematic Review Methods to the Identification and Evaluation of Mechanistic Data, Dr. Daniele Wikoff, Sunday, March 19th, 8:15 AM, Music City Center, Room 202
Exhibitor Hosted Session
- Modern Strategies to Evaluate Drug Impurities, Drs. Amy L. Mihalchik, DABT, R.A.C., Neepa Y. Choksi, Isabel Lea, and Marcie L. Wood, Monday, March 20th, 12:00 PM, Music City Center, Room 101A.
- Evaluation of drug impurities is a critical, occasionally overlooked aspect of drug safety. ToxStrategies consultants will present case studies of strategies and tools used to address safety of impurities present in prescription and non-prescription drugs, including targeted literature searches, read-across, and QSAR approaches.
- Participants will learn essential strategies to evaluate impurities in prescription and non-prescription drugs, and overall considerations to effectively support the safety of data-rich and data-poor impurities, including criteria for valid read-across rationales and integration of QSAR methods in drug impurity safety assessment.
Workshop and Symposium Sessions
- Continuing Towards Best Practices in Organizing, Assessing, and Applying Mechanistic Data in Hazard Characterization and Risk Assessment, Dr. Daniele Wikoff, Tuesday, March 21st, 8:00 AM, Music City Center, Karl Dean Ballroom
- Placental Biology, Toxicology, and In Vitro Modeling for Predictive Developmental Toxicology, Dr. John M. Rogers, Tuesday, March 21st, 1:00 PM, Music City Center, Karl Dean Ballroom
- Refining Inhalation Risk Assessments by Integrating New Approach Methodologies, Dr. William D. Klaren, Thursday, March 23rd, 8:30 AM, Music City Center, Room 207B
Educational-Career Development Session
- A Day in the Life of an Industry Toxicologist, Dr. Allison Franzen, Wednesday, March 22nd, 11:00 AM, Music City Center, Room 202